Your session is about to expire
← Back to Search
Ciprofloxacin vs Levofloxacin for Stem Cell Transplant Prophylaxis
Study Summary
This trialstudied 2 antibiotics for prophylaxis in stem cell transplants. Results suggest one may be better than the other, but more research is needed.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 75 years old and have been diagnosed with a blood cancer.I have a long QT interval on my ECG.You are allergic to ciprofloxacin or levofloxacin.I am eligible for a stem cell transplant according to the program's criteria.
- Group 1: Levo
- Group 2: Cipro
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there availability for volunteers to participate in this experiment?
"According to the clinicaltrials.gov database, this research endeavour has been continuously recruiting since its initial post on March 14th 2018 and was last updated October 24th 2022."
How many participants are currently receiving treatment in this medical experiment?
"Affirmative. Clinicaltrials.gov's records demonstrate that this medical trial is currently enrolling, having first appeared on March 14th 2018 and been updated as recently as October 24th 2022. The study necessitates 308 patients to join from a single site."
Is participation in this medical study open to new enrollees?
"This research project seeks to recruit 308 patients aged between 18 and 75 that are undergoing prophylaxis. In addition, the following prerequisites must be satisfied: having a hematological malignancy, meeting stem cell transplant program criteria for autologous/allogeneic hematopoietic stem cell transplantation."
Is this research project extending its recruitment to individuals aged 35 and over?
"This medical trial is open to individuals aged 18 and above, up to a maximum of 75."
Has the FDA authorized Levofloxacin for public use?
"Given the lack of efficacy data for this Phase 2 trial, our team at Power assigned Levofloxacin a safety rating of 2."
What applications does Levofloxacin have for medical treatment?
"Levofloxacin is the usual treatment for otitis externa, as well as pyoderma, entercococcus faecalis-caused UTI and abdominal infection."
Share this study with friends
Copy Link
Messenger